Clinical trial NCT06930898: Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform
Official title: Improving Breast Health Knowledge Among Women Using a Gamified Metaverse-Based Platform: A Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Health Education
Breast Neoplasms
Keywords: Gamification
Health Education
Breast Cancer Awareness
Metaverse
Women&amp;#39;s Health
Digital Health Literacy
Lead sponsor: University of Malaya
Sponsor class: OTHER
First posted: 2025-04-16
Enrollment: 72
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Participants were randomly assigned in a 1:1 ratio to one of two parallel groups: a gamified version of the Mammoverse metaverse-based platform or a non-gamified version containing the same educational content.
Primary purpose: OTHER

Brief summary: This randomized controlled trial aimed to evaluate the effectiveness of Mammoverse, a gamified metaverse-based educational platform, in improving breast health knowledge among women in China. Participants were randomly assigned to either a gamified or non-gamified version of the platform. Both groups received identical educational content, but only the gamified group experienced interactive game elements such as avatars, progress feedback, and rewards. Knowledge was assessed at baseline, immediately post-intervention, and at 4-week follow-up. The study found that the gamified platform significantly improved knowledge retention and participant engagement compared to the non-gamified version.

This ClinicalTrials.gov registration reflects only the randomized controlled trial (RCT) portion of a broader mixed-methods study that was approved by the University of Malaya Research Ethics Committee (Ref: UM.TNC2/UMREC_3967). The full study protocol includes three methodological approaches, and this registration pertains specifically to the RCT component involving the Mammoverse platform. Other study components are not included in this registration.

Detailed description: Mammoverse is a 3D metaverse environment designed to promote breast health knowledge through immersive and interactive learning. The gamified version included user avatars, badges, tasks, and personalized feedback to increase motivation and engagement. The study recruited 72 women aged 18 and above, and used a pre-post-follow-up design. Outcome measures were based on an adapted 18-item Breast Health Literacy Questionnaire. The trial was conducted entirely online, with ethics approval from the University of Malaya Research Ethics Committee.

Eligibility criteria: Inclusion Criteria:

* Female participants aged 18 years and above
* Able to read and understand Chinese
* Access to a digital device and stable internet connection
* Willing to provide informed consent

Exclusion Criteria:

* Cognitive impairment or mental health condition that affects participation
* Inability to complete the full intervention and follow-up sessions
* Incomplete baseline assessment

Primary outcomes:
measure: Change in Breast Health Knowledge Score from Baseline to 4 Weeks Post-Intervention
timeFrame: Baseline and 4 weeks post-intervention
Secondary outcomes:
measure: Change in Breast Health Knowledge Score from Baseline to Immediately Post-Intervention
timeFrame: Baseline and immediately post-intervention
Other outcomes:
measure: Knowledge Retention from Immediately Post-Intervention to 4 Weeks Post
timeFrame: Immediately post-intervention and 4 weeks post-intervention
Locations:
city: Hangzhou
country: China
facility: Online Recruitment - Hangzhou, Zhejiang, China
state: Zhejiang
city: Kuala Lumpur
country: Malaysia
facility: University of Malaya
Study officials:
affiliation: University of Malaya
name: Rui Li, PhD(c)
role: PRINCIPAL_INVESTIGATOR
References: